LEADER 00000pam  22000004a 4500 
001    ocn156994507 
003    OCoLC 
005    20080301104133.0 
008    070719t20082008ilua     b    001 0 eng   
010      2007029867 
016 7  101312248|2DNLM 
020    9781566636278|qcloth|qalkaline paper 
020    1566636272|qcloth|qalkaline paper 
035    (OCoLC)156994507 
035    (Sirsi) i9781566636278 
040    DNLM/DLC|beng|cDLC|dYDX|dNLM|dBAKER|dBTCTA|dYDXCP 
042    pcc 
043    n-us--- 
049    CKEA 
050 00 RC280.P7|bJ87 2008 
060 10 WJ 762|bJ96d 2008 
082 00 616.99/463061|222 
100 1  Justman, Stewart. 
245 10 Do no harm :|bhow a magic bullet for prostate cancer 
       became a medical quandary /|cStewart Justman. 
264  1 Chicago :|bIvan R. Dee,|c[2008] 
264  4 |c©2008 
300    xii, 236 pages :|billustrations ;|c23 cm 
336    text|btxt|2rdacontent 
337    unmediated|bn|2rdamedia 
338    volume|bnc|2rdacarrier 
504    Includes bibliographical references (pages 225-231) and 
       index. 
505 0  A medical maze: the finasteride question -- The prostate 
       cancer prevention trial -- Sister drugs: finasteride and 
       tamoxifen -- Specific harms and general benefits -- 
       Calculation of harm -- Medical knowledge and medical 
       ignorance -- Prevention gone too far -- Breakthrough: "the
       present is obsolete" -- "I will abstain from harming any 
       man" -- "Do no harm?" -- The finasteride story: what did 
       not happen. 
650  0 Finasteride|xTherapeutic use|zUnited States. 
650  0 Prostate|xCancer|xChemoprevention|zUnited States. 
650  0 Prostate|xDiseases|xChemoprevention|zUnited States. 
650 12 Finasteride|xadverse effects|zUnited States. 
650 12 Prostatic Neoplasms|xprevention & control|zUnited States. 
650 22 Clinical Trials as Topic|zUnited States. 
650 22 Finasteride|xtherapeutic use|zUnited States. 
994    92|bCKE